MERS-CoV: clinical decision making support for treatment
- Public Health England
- Part of:
- Middle East respiratory syndrome coronavirus (MERS-CoV): clinical management and guidance
- 25 June 2014
- Last updated:
- 16 August 2017, see all updates
Information for clinicians from PHE and ISARIC (International Severe Acute Respiratory & Emerging Infection Consortium).
Ref: PHE publications gateway number: 2015319 PDF, 636KB, 43 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
An overview of available evidence and experience on investigational therapeutics for clinicians treating confirmed cases of MERS-CoV.
Published: 25 June 2014
Updated: 16 August 2017
- Updated with clinical trials data and added additional sections on novel therapeutic agents undergoing investigation.
- Updated with version 3, September 2015.
- First published.